Brianna N. Smith

Pevonedistat and azacitidine upregulate NOXA (PMAIP1) to increase sensitivity to venetoclax in preclinical models of acute myeloid leukemia

Dan Cojocari, Brianna N. Smith, Julie J. Purkal et al. · Haematologica · 2021 · 37 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Pharmacotherapy +18

Ribosome subunit attrition and activation of the p53–MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition

Gregory C. Howard, Jing Wang, Kristie L. Rose et al. · eLife · 2023 · 18 citations · Full text

Selective inhibition of MCL1 overcomes venetoclax resistance in a murine model of myelodysplastic syndromes

Melissa A. Fischer, Yuanbin Song, Maria P. Arrate et al. · Haematologica · 2022 · 11 citations · Full text

Hematological Malignancy, Radiation Oncology, Mixed-phenotype Acute Leukemia +15

K562/GM-CSF vaccination reduces tumor burden, including achieving molecular remissions, in chronic myeloid leukemia (CML) patients (PTS) with residual disease on imatinib mesylate (IM)

Brianna N. Smith, Yvette L. Kasamon, Carole B. Miller et al. · Journal of Clinical Oncology · 2006 · 10 citations

Disease Burden, Immunology, Immunoediting +25